The performance of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the expiry in key territories has introduced considerable volatility. Investors are now facing the impact of rival medications , redu